Market

American Airlines Group Inc Ranked Among Today’s Top Shorts As COVID-19 Concerns Continue To Rise

After the Dow Jones and S&P 500 registered a fourth straight day of losses, it looks like the week is ending with a much-needed bounce. The Dow rose about 210 points, the S&P 500 rebounded by 0.6%, and the Nasdaq
NDAQ
added another 0.6%. Following Thursday’s second straight pandemic-era low in jobless claims, recovery plays led the day’s gains. Airlines and energy stocks moved higher, while financial stocks such as Wells Fargo
WFC
also bounced. Meanwhile, President Biden stiffened his stance on vaccines, outlining a plan to mandate Covid vaccines for millions of private-sector workers and Federal employees. Investors continue to monitor the Federal Reserve’s monetary policy and anticipate its September 21-22 meetings. Inflation continues to be a concern, with producer prices jumping a record 8.3% for August. If you’re looking for a way to play this market, the deep learning algorithms at Q.ai have crunched the data to give you a set of Top Shorts. Our Artificial Intelligence (“AI”) systems assessed each firm on parameters of Technicals, Growth, Low Volatility Momentum, and Quality Value to find the best short plays.  

Sign up for the free Forbes AI Investor newsletter here to join an exclusive AI investing community and get premium investing ideas before markets open.

American Airlines Group Inc (AAL)

American Airlines is our first Top Short today. American Airlines is the largest airline in the world in terms of the number of passengers carried, fleet size, and scheduled passenger-kilometers. While the upside is evident for airline travel, due to pent-up demand, nobody truly knows when travel demand will return to pre-pandemic levels. Especially with the Delta variant, other emerging variants, and waning vaccine efficacy threatening to derail everything. Our AI systems rated American Airlines D in Technicals, D in Growth, F in Low Volatility Momentum, and F in Quality Value. The stock closed 5.59% to $20.2 on volume of 60,077,160 vs its 10-day price average of $19.72 and its 22-day price average of $19.74, and is up 33.51% for the year. Revenue grew by 7.78% in the last fiscal year, Operating Income grew by -10.81% in the last fiscal year, and EPS grew by -46.38% in the last fiscal year. Revenue was $17337.0M in the last fiscal year compared to $44541.0M three years ago, Operating Income was $(11058.0)M in the last fiscal year compared to $3757.0M three years ago, and EPS was $(18.36) in the last fiscal year compared to $3.03 three years ago. Forward 12M Revenue is also expected to grow by 32.58% over the next 12 months. 

MORE FROM FORBESAmerican Airlines Group (AAL)

Beyond Meat Inc (BYND)

Beyond Meat Inc is our second Top Short today. Beyond Meat has become the face of the plant-based food revolution, and has become a major producer of plant-based meat substitutes such as beef, meatballs, ground meat, and pork sausage links and patties. Our AI systems rated the company D in Technicals, F in Growth, D in Low Volatility Momentum, and F in Quality Value. The stock closed up 1.4% to $114.13 on volume of 2,536,439 vs its 10-day price average of $117.77 and its 22-day price average of $119.58, and is down 9.11% for the year. Revenue grew by 11.6% in the last fiscal year and grew by 416.25% over the last three fiscal years, while EPS grew by -69.45% over the last three fiscal years. Revenue was $406.78M in the last fiscal year compared to $87.93M three years ago, Operating Income was $(31.52)M in the last fiscal year compared to $(26.47)M three years ago, EPS was $(0.85) in the last fiscal year compared to $(4.75) three years ago, and ROE was (14.04%) in the last year compared to (45.95%) three years ago. Forward 12M Revenue is also expected to grow by 21.61% over the next 12 months.

MORE FROM FORBESBeyond Meat (BYND)

Inari Medical Inc (NARI)

Inari Medical Inc is our third Top Short today. Inari Medical is a medical innovator, with a suite of products aiming to extract large clots from large vessels without the need for thrombolytics or an ICU stay. Our AI systems rated the company F in Technicals, F in Growth, F in Low Volatility Momentum, and F in Quality Value. The stock closed down 0.59% to $81.26 on volume of 578,279 vs its 10-day price average of $81.35 and its 22-day price average of $78.73, and is down 4.25% for the year. Revenue grew by 49.05% in the last fiscal year and grew by 2948.4% over the last three fiscal years, Operating Income grew by 38.43% in the last fiscal year and grew by -400.16% over the last three fiscal years, and EPS grew by 67.12% in the last fiscal year and grew by -122.45% over the last three fiscal years. Revenue was $139.67M in the last fiscal year compared to $6.83M three years ago, Operating Income was $19.76M in the last fiscal year compared to $(9.11)M three years ago, EPS was $0.27 in the last fiscal year compared to $(2.01) three years ago, and ROE was 12.74% in the last year. Forward 12M Revenue is expected to grow by 10.8% over the next 12 months, and the stock is trading with a Forward 12M P/E of 284.13.

Sabre Corp (SABR)

Our final Top Short today is Sabre Corp. Sabre, which was initially founded by American Airlines in 1960, is the largest global distribution systems provider for air bookings in North America. Our AI systems rated Sabre D in Technicals, D in Growth, C in Low Volatility Momentum, and F in Quality Value. The stock closed up 2.39% to $11.12 on volume of 4,847,650 vs its 10-day price average of $11.04 and its 22-day price average of $10.83, and is down 0.8% for the year. Revenue grew by 0.38% in the last fiscal year, while Operating Income grew by -7.25% in the last fiscal year, and EPS grew by -17.01% in the last fiscal year. Revenue was $1334.1M in the last fiscal year compared to $3866.96M three years ago, Operating Income was $(912.96)M in the last fiscal year compared to $570.34M three years ago, EPS was $(4.42) in the last fiscal year compared to $1.22 three years ago, and ROE was (194.51%) in the last year compared to 40.76% three years ago. Forward 12M Revenue is also expected to grow by 33.33% over the next 12 months. 

MORE FROM FORBESSabre (SABR)

Liked what you read? Sign up for our free Forbes AI Investor Newsletter here to get AI driven investing ideas weekly. For a limited time, subscribers can join an exclusive slack group to get these ideas before markets open.

Most Related Links :
todayuknews Governmental News Finance News

Source link

Back to top button